{"name":"PMV Pharmaceuticals, Inc","slug":"pmv-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPUmNiQWExQllxX0RjT3RLZU5BR3J3NFo2R0VxMUlZV0pVSlNyV0tJX19rZS16ak9mMG5FcHh6c0JuY3ZBRW93M3c4dkNzNUliS0I0VUJ3RzNEUFZMbVdwM1ZCbTVYcGthQzRnQWQ0Vmx5dDhvRGJmbGU1eUpzcUZtd0xfTjF4dm1GRERZ?oc=5","date":"2026-03-06","type":"pipeline","source":"Yahoo Finance","summary":"PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights - Yahoo Finance","headline":"PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugJBVV95cUxNYVJKMGhBUDZDMl9DWXBQRkxVYWxYY19ZaFZ2TFFNZXZzM2lfXzJWajRCRS0xWVZKVWRYYmlGOURfUmR5Q3VhMnBvRE83eHhET2YteDNYRmtrMVBhdGw3Smk1V1dGZHBveXc3SklZdEhQY0VwblEtRHA5cUZramJpaWV0S250Y2cwWnFabExBSmxDYmM1Q3E5VE5FVXpkT3YxdnlDcUkzLVFhZXZXZlFzZVl5UzgzdGhNdUFxaFFjS0psS0doLWlvUXJFaUMzN2taUXVqSHREcEltQUxkZEN5dGRKWXU3WVRxYzFDYTY2Z01aT3dUb1M2N0dVWFpaUlBpSWp5dE1qNXRoQkVYazQ4a0E4U0syWFhRNmZjaEdZVTNBRGVqb2owWGxGblBCbzBqZ0FlTGh6NWJ5UQ?oc=5","date":"2026-02-26","type":"pipeline","source":"GlobeNewswire","summary":"New England Journal of Medicine Publishes First-in-Human - GlobeNewswire","headline":"New England Journal of Medicine Publishes First-in-Human","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOTlplaC1XSVdKUmpOeGZuaVNsSmNWdFpmRnNUWFUzWEFIaVdpdlFmcGZuMzBEM3M1MndVRTc4aDdzOHpkVTZ6Sktsa0lLN1FlUEdoOE5ROWhKeVB3aE1Bd2drYW1ST1lDUlVTazI5RExfbVNIc0dKNXg3MVIxWjZ4ZDc1TlppbDVUalRqbFZxUWZfMU5HUFVSWng1aWIxWlN5SFhEZ3lJYWFWQlUzcXI2OGxGamFmZzNPMk5kYXR0dw?oc=5","date":"2026-02-26","type":"trial","source":"Stock Titan","summary":"Pill reactivates mutant p53 tumor suppressor in first-in-human cancer trial - Stock Titan","headline":"Pill reactivates mutant p53 tumor suppressor in first-in-human cancer trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQRS1jZ2pxRnZ3bTRlZ0dwYTlNclFGS2ZCdlFYYWZzVTFsczh0MEJUZ2NxQ1JxbEdERmVXckNSX0t4amJsdlhJem93NE45LXUwd24xUXRlSG8wX0FuTU9PX3prU0dvMjVfclhGV2J6bVJYNmJjMmZJdklEWjNnenowVGQ3YWRPVjR4TmJuRnA1ZVJSdUZldXJ2WThsRFNBSWJXOHkzX19VM2N3VTlNS1VwUHJ5SWdUR3A5TkE?oc=5","date":"2026-02-26","type":"trial","source":"Investing.com","summary":"PMV Pharma’s rezatapopt study published in New England Journal - Investing.com","headline":"PMV Pharma’s rezatapopt study published in New England Journal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE4xMHVKU1RITHdrZjVaUW1md05BUnU3UzhLMG82YXJHUWtDYnpMTDFEU051UjVWVlFDLTcyb3dpQTZQcTVnempQbmM0ekhjeVBPVlp2NDJyMHl1QllIR3ZF?oc=5","date":"2026-01-13","type":"trial","source":"Nature","summary":"Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson - Nature","headline":"Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQblhKSWFyLWNyZWs5aWdRZmhKRGpoVUx1cjR5ZWxMQTk2djFiMm82WW1hZU9MZ3M3VzE5UHhESWlzeUZMYTIzVzNfQ0E0ZXFmWUJoNmRwQ2trQXJTMXJkTDJqNnVVcVNzMlNSb3hxTFlQdGdmbGs1WUluX1hoWV9XZU9TcXZlUjRWME5pTEYxZTBxYjlUZmdycURiN2llZXFXVlRZ?oc=5","date":"2026-01-09","type":"trial","source":"The Pharma Letter","summary":"PMV Pharma leaps on promising rezatapopt monotherapy data - The Pharma Letter","headline":"PMV Pharma leaps on promising rezatapopt monotherapy data","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNMXFZV0xpUUlPZTVkd09WU2NrSVpWcmJzSGFaUHp5MWlERVBNdm02TUI0eTRDMnB4cVpwSVZ6QTh1QWNvckFlRGtHZ1o1UzNmdlY4Wkh0S3FhY3Nza1diYUlPcnVOVi10aTg3enVkUllQWXUtLXM4NzJYcTVhNjJodGRVSUc4RTB4bEJZVUVkVkQ?oc=5","date":"2025-11-12","type":"earnings","source":"Yahoo Finance","summary":"PMV Pharmaceuticals Reports Third Quarter 2025 Financial Results and Corporate Highlights - Yahoo Finance","headline":"PMV Pharmaceuticals Reports Third Quarter 2025 Financial Results and Corporate Highlights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxOUE54QUxncWQydVdySWZMcy1OM3lUWk5RQjR2R0pNS09JSm90aUxyMDNmV0ZfOWR3ZHhVNUMtWkpId3RwT1RzbU53U0NCYThqSlhSQmZ4OGlZVG51ZE80V0o3bkVmVmdYMVhxaVFkSlluVnhlLUk5eDlTNldfQkxHNU51OHhqZmo1UVpHeWZDbk1vTjN0RzJFdmN2ZF9PV29GN2dxREhPWERyTnNhNXZmczZ3UThfelU5dE5hX0NVVm11Und2SUVtbUVnTWgxdXM?oc=5","date":"2025-10-25","type":"pipeline","source":"seekingalpha.com","summary":"PMV Pharmaceuticals, Inc. (PMVP) Presents at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - Slideshow (NASDAQ:PMVP) 2025-10-25 - seekingalpha.com","headline":"PMV Pharmaceuticals, Inc. (PMVP) Presents at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer The","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxPejhjWElxMHFPdGxXaVc2WFFEV0tpYUl4dktTeHBIUVdGTXB2OVBMeHZqWGhsV3ROTjJydlBFZGp0RXRkR0xkNHROT0xSalNSdjdUVGo5dXU0WlNScHdCc2pVQ3JzUHlhV0hmaEtndVZTSTYxZElOTGVESUhZT2ZhUFJfQkV1TVVwTVdNY2ZLMHZQT2V0NzhMZE0zY3d2dTBNYjFJNnhTZXJjcHBQU044NjB6ejhnLTZrMmJ3b0t5XzU1ZWxfY2lMUVpfU1JCUXJjS0g1YVNJWVB2aVpGT3QwSVNwYVp2SV9UU2V4YVQzcWNNY0s1Z1RYc2hFR01waDZLUi0tMkR6RzM5TzBQNzVZeXo1WGlhby00TnY5ZzV5V1diYm5JZkNndk53?oc=5","date":"2025-10-13","type":"trial","source":"Quiver Quantitative","summary":"PMV Pharmaceuticals Announces Oral Presentation of Initial Data from Phase 2 Study of Rezatapopt for TP53 Y220C Mutant Advanced Solid Tumors at AACR-NCI-EORTC Conference - Quiver Quantitative","headline":"PMV Pharmaceuticals Announces Oral Presentation of Initial Data from Phase 2 Study of Rezatapopt for TP53 Y220C Mutant A","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-13","type":"trial","source":"GlobeNewswire","summary":"PMV Pharmaceuticals to Present Rezatapopt Pivotal Phase 2 - GlobeNewswire","headline":"PMV Pharmaceuticals to Present Rezatapopt Pivotal Phase 2","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AJBVV95cUxNYkROVXBUdUw1UHBmTTQ3akZxc1E1Q1ctb0F4OVVjZlJZRGN6TTlyN1BLLW01d1lfM2RXU1VFektRaTJZV3NJSWRUUWY5enRLbjhmcURSaXhBQVlOUjRHZUVmZVNMb3JHSGI2dEVuaVZBOVJsQzdGdElVdV93a3hsQlZMSWFESjBZeldxeU5GbU9YS2tEenB3OUx6NXk0V0p6Q05LNUxBOUJqSUJqZld5NjNvLVRxMTM4blN1amxVUktSOGFSVk8yQTNJODIyVlhZWl9yX2xURlZHSDBKZThoQW8xckhMOWxHR0RvN3BIcGNFa0dtWmo4WWlMR3lydUdud2pHdVF6V0NiZ0hPaVRsZEJkSGdUOUhYMzVycUpWQklZQlg3Wl83QVVxeXZHdmMtcFpPb0hwMXpiaTFrMlNJekJuMkZ6a3FTaE0xWVoxTVY?oc=5","date":"2025-09-10","type":"trial","source":"GlobeNewswire","summary":"PMV Pharmaceuticals Announces Promising Rezatapopt Monotherapy Interim Data From PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation - GlobeNewswire","headline":"PMV Pharmaceuticals Announces Promising Rezatapopt Monotherapy Interim Data From PYNNACLE Phase 2 Trial Across Multiple ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPVEVTVm9aRFhnbWpCMGNRTGVRV3VUMjVSdFYzVlBTcFZyUjJtTWVLQ2NxSWlIc0dBREhWejJySmFuMWdOSDlUWHd2aUo1WEp4Z2MxOXJjcWFRc19DN05mbjVwYWFKUzJMT2dOYzdiN0tDQ0lXaXZ0UENYX1gzRnBmcmU4MEVvVjFHbGZ0WmdPTlRCUnBZMXlVVy1pQQ?oc=5","date":"2024-01-19","type":"regulatory","source":"Fierce Biotech","summary":"PMV lays off 30% to fund phase 2 trial of remaining solid tumor drug - Fierce Biotech","headline":"PMV lays off 30% to fund phase 2 trial of remaining solid tumor drug","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}